eEF2K activity determines synergy to co-treatment of cancer cells with PI3K and MEK inhibitors

Published: 9 July 2021| Version 1 | DOI: 10.17632/xjsdxnpxkb.1
Contributor:
Maruan Hijazi Vega

Description

Original data from Western blots

Files

Institutions

Barts Cancer Institute

Categories

Western Blot

License